Ronald Kay Science Fellowship for 2018 - Research • Breast Cancer Foundation NZ

What COVID-19 means for people with breast cancer

Ronald Kay Science Fellowship for 2018

Dr Barbara Lipert at the University of Auckland
Dr Barbara Lipert at the University of Auckland
April 2018

What is the problem and who is affected?

Dr Barbara Lipert, a research fellow at the University of Auckland, is investigating resistance to Kadcyla, a relatively new drug for advanced HER2+ breast cancer that has been recommended for funding by PHARMAC, but with a low priority ranking until further investigations are completed.

What is this research hoping to achieve?

Dr Lipert plans to build on work at Auckland University that has already identified several genes that could be factors in resistance to Kadcyla. “We need to evaluate these findings in a multistage process now. This knowledge will help clinicians and patients make informed decisions in choosing the best treatment strategy, bringing us closer to making personalised medicine a reality in breast cancer treatment in New Zealand.”